IMMUNOMEDICS INC Contracts & Agreements

Agreement and Plan of Merger, dated September 13, 2020, among Immunomedics, Inc., Gilead Sciences, Inc. and Maui Merger Sub, Inc (Filed With SEC on September 14, 2020)

Forms of Incentive Stock Option Notice and Incentive Stock Option Agreement under the Immunomedics, Inc. Amended and Restated 2014 Long-Term Incentive Plan (Filed With SEC on August 5, 2020)

Forms of Nonqualified Stock Option Notice and Nonqualified Stock Option Agreement under the Immunomedics, Inc. Amended and Restated 2014 Long-Term Incentive Plan (Filed With SEC on August 5, 2020)

Forms of Restricted Stock Units Notice and Restricted Stock Units Agreement (for Officers/Employees) under the Immunomedics, Inc. Amended and Restated 2014 Long-Term Plan (Filed With SEC on August 5, 2020)

Forms of Restricted Stock Units Notice and Restricted Stock Units Agreement (for Directors) under the Immunomedics, Inc. Amended and Restated 2014 Long-Term Incentive Plan (Filed With SEC on August 5, 2020)

Immunomedics, Inc. Amended and Restated 2014 Long-Term Incentive Plan (Filed With SEC on June 18, 2020)

Separation Agreement, dated May 27, 2020, by and between Immunomedics, Inc. and Harout Semerjian (Filed With SEC on May 27, 2020)

Executive Employment Agreement, dated as of February 13, 2020, by and between the Company and Loretta Itri (Filed With SEC on May 6, 2020)

Incentive Stock Option Grant, dated as of February 13, 2020, by and between the Company and Loretta Itri (Filed With SEC on May 6, 2020)

Executive Employment Agreement, dated as of April 16, 2020, by and between the Company and Harout Semerjian (Filed With SEC on May 6, 2020)

Nonqualified Stock Option Grant, dated as of April 16, 2020, by and between the Company and Harout Semerjian (Filed With SEC on May 6, 2020)

Time-Based Restricted Stock Unit Agreement, dated as of April 16, 2020, by and between the Company and Harout Semerjian (Filed With SEC on May 6, 2020)

Performance-Based Restricted Stock Unit Agreement, dated as of April 16, 2020, by and between the Company and Harout Semerjian (Filed With SEC on May 6, 2020)

Underwriting Agreement by and among Immunomedics, Inc., Cowen and Company, LLC, BofA Securities, Inc. and Jefferies LLC, as representatives of the underwriters named therein,... (Filed With SEC on May 1, 2020)

Description of Securities of the Registrant, dated as of December 31, 2019 (Filed With SEC on February 27, 2020)

Lease Agreement dated October 27, 2017 with WU/LH 400 American L.L.C (Filed With SEC on February 27, 2020)

Underwriting Agreement by and among the Company, Goldman Sachs & Co. LLC and BofA Securities, Inc., as representatives of the underwriters named therein, dated December 4, 2019 (Filed With SEC on December 9, 2019)

Consulting Agreement, dated as of May 28, 2019, by and between Immunomedics, Inc. and Dr. Robert Iannone (Filed With SEC on August 7, 2019)

Promotion Agreement, dated as of April 5, 2019, by and between Immunomedics, Inc. and Janssen Biotech, Inc (Filed With SEC on August 7, 2019)

License Agreement, dated as of April 29, 2019, by and between Immunomedics, Inc. and Everest Medicines II Limited (Filed With SEC on August 7, 2019)

Letter Agreement, dated as of March 5, 2019, by and between the Company and Scott Canute (Filed With SEC on May 9, 2019)

Separation Agreement, dated as of March 13, 2019, by and between the Company and Michael Pehl (Filed With SEC on May 9, 2019)

Executive Employment Agreement, dated as of August 7, 2017, by and between the Company and Usama Malik (Filed With SEC on May 9, 2019)

Sales Agreement, dated as of March 29, 2019, by and between Immunomedics, Inc. and Cowen and Company, LLC (Filed With SEC on March 29, 2019)

Form of Exchange Agreement, dated October 2, 2018, between the Company and certain of the Company's noteholders (Filed With SEC on November 7, 2018)

Transition Agreement, dated as of August 23, 2018, between the Company and Michael Garone (Filed With SEC on November 7, 2018)

Master Services Agreement, dated as of September 11, 2018, between the Company and Samsung BioLogics Co., Ltd (Filed With SEC on November 7, 2018)

Product Specific Agreement, dated as of September 11, 2018, between the Company and Samsung BioLogics Co., Ltd (Filed With SEC on November 7, 2018)

Executive Employment Agreement, dated as of September 24, 2018, between the Company and Jared Freedberg (Filed With SEC on November 7, 2018)

Nonqualified Stock Option Grant, dated as of September 24, 2018, between the Company and Jared Freedberg (Filed With SEC on November 7, 2018)

Executive Employment Agreement, dated as of September 26, 2018, between the Company and Kurt Andrews (Filed With SEC on November 7, 2018)

Nonqualified Stock Option Grant, dated as of July 11, 2018, between the Company and Kurt Andrews (Filed With SEC on November 7, 2018)

Immunomedics, Inc. Annual Cash Bonus Plan (Filed With SEC on November 7, 2018)

Letter Agreement, dated as of July 6, 2018, by and between the Company and BSP Pharmaceuticals S.p.A (Filed With SEC on August 23, 2018)

License Agreement, dated as of April 4, 2018, by and between the Company and The Scripps Research Institute (Filed With SEC on August 23, 2018)

Underwriting Agreement by and among the Company, Morgan Stanley & Co. LLC, and Cowen and Company, LLC and Jefferies LLC, as representatives of the underwriters named therein,... (Filed With SEC on June 15, 2018)

Funding Agreement, dated as of January 7, 2018, between the Company and RPI Finance Trust (Filed With SEC on May 9, 2018)

Common Stock Purchase Agreement, dated as of January 7, 2018, between the Company and RPI Finance Trust (Filed With SEC on May 9, 2018)

Executive Employment Agreement, dated as of March 27, 2018, between the Company and Robert Iannone (Filed With SEC on May 9, 2018)

Incentive Stock Option Grant, dated as of April 9, 2018, between the Company and Robert Iannone (Filed With SEC on May 9, 2018)

Nonqualified Stock Option Grant, dated as of April 9, 2018, between the Company and Robert Iannone (Filed With SEC on May 9, 2018)

Executive Employment Agreement, dated as of November 8, 2017, between the Company and Michael Pehl (Filed With SEC on February 8, 2018)

Incentive Stock Option Grant, dated as of December 7, 2017, between the Company and Michael Pehl (Filed With SEC on February 8, 2018)

Nonqualified Stock Option Grant, dated as of December 7, 2017, between the Company and Michael Pehl (Filed With SEC on February 8, 2018)

Executive Employment Agreement, dated as of November 8, 2017, between the Company and Brendan Delaney (Filed With SEC on February 8, 2018)

Incentive Stock Option Grant, dated as of November 10, 2017, between the Company and Brendan Delaney (Filed With SEC on February 8, 2018)

Form of Indemnification Agreement (Filed With SEC on December 6, 2017)

Master Services Agreement, dated as of July 3, 2017, between the Company and Covance, Inc (Filed With SEC on November 9, 2017)

Work Order, dated as of July 3, 2017, between the Company and Covance, Inc (Filed With SEC on November 9, 2017)

Stipulation and Agreement of Settlement, Compromise, and Release, dated November 2, 2017, by and among Immunomedics, Inc., venBio Select Advisor LLC, Dr. David M. Goldenberg,... (Filed With SEC on November 8, 2017)

Form of Exchange Agreement (Filed With SEC on September 15, 2017)

TERMINATION AGREEMENT (Filed With SEC on August 16, 2017)

DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on May 10, 2017)

STOCK PURCHASE AGREEMENT (Filed With SEC on May 10, 2017)

WARRANT AGREEMENT (Filed With SEC on February 16, 2017)

INDEMNIFICATION AGREEMENT (Filed With SEC on February 16, 2017)

WARRANT AGREEMENT (Filed With SEC on October 12, 2016)

IMMUNOMEDICS, INC. 10,000,000 Shares of Common Stock and Warrants to Purchase 10,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 11, 2016)

AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on February 3, 2016)

Amended andRestated Employment Agreement by and between Immunomedics, Inc. and Dr. David M. Goldenberg Effective as of July 1, 2015 TABLE OF CONTENTS (Filed With SEC on July 16, 2015)

IMMUNOMEDICS, INC. RESTRICTED STOCK UNITS NOTICE UNDER THE IMMUNOMEDICS, INC. 2014 LONG-TERM INCENTIVE PLAN (Filed With SEC on July 16, 2015)

IMMUNOMEDICS, INC. RESTRICTED STOCK UNITS AGREEMENT UNDER THE IMMUNOMEDICS, INC. 2014 LONG-TERM INCENTIVE PLAN (Filed With SEC on July 16, 2015)

IMMUNOMEDICS, INC. (Filed With SEC on February 12, 2015)

FIFTH AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on June 25, 2014)

IMMUNOMEDICS, INC. 9,000,000Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 2, 2014)

PART ONE DEFINITIONS (Filed With SEC on March 7, 2014)

IMMUNOMEDICS LETTERHEAD (Filed With SEC on November 4, 2013)

IMMUNOMEDICS, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT RECITALS (Filed With SEC on August 22, 2013)

IMMUNOMEDICS, INC. PERFORMANCE-BASED RESTRICTED STOCK UNIT ISSUANCE AGREEMENT RECITALS (Filed With SEC on August 22, 2013)

6,086,956 Shares IMMUNOMEDICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 22, 2013)

AMENDMENT AGREEMENT Re: Epratuzumab Development, Collaboration and License Agreement (Filed With SEC on February 8, 2012)

IMMUNOMEDICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on February 8, 2012)

American Enterprise Park Morris Plains, New Jersey Immunomedics, Inc. SIXTH AMENDMENT Extension Agreement (Filed With SEC on August 24, 2011)

FOURTH AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on July 8, 2011)

Third Amended and Restated Employment Agreement by and betweenImmunomedics, Inc. and Dr. David M. Goldenberg Dated as of July 1, 2011 TABLE OF CONTENTS (Filed With SEC on July 8, 2011)

American Enterprise Park Morris Plains, New Jersey Immunomedics, Inc. SIXTH AMENDMENT Extension Agreement (Filed With SEC on May 10, 2011)

Tel ###-###-#### Web:www.immunomedics.com FAX ###-###-#### (Filed With SEC on February 4, 2011)

Tel. (973 ###-###-#### Web www.immunomedics.com FAX ###-###-#### (Filed With SEC on February 4, 2011)

THIRD AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 26, 2010)

American Enterprise Park Morris Plains, New Jersey (Filed With SEC on August 27, 2009)

Second Amended and Restated Employment Agreement by and between Immunomedics, Inc. and Dr. David M. Goldenberg Dated as of December 17, 2008 TABLE OF CONTENTS (Filed With SEC on December 22, 2008)

SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 22, 2008)

IMMUNOMEDICS, INC. LETTERHEAD (Filed With SEC on December 22, 2008)

executed by andbetween IMMUNOMEDICS, INC., as the Borrower and BANK OF AMERICA, N.A., as the Bank Dated: June 6, 2008 (Filed With SEC on August 29, 2008)

LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on August 29, 2008)

AMENDMENT NO. 1 TO AMENDED AND RESTATED (Filed With SEC on February 6, 2008)

TERMINATION AGREEMENT (Filed With SEC on December 26, 2007)

IMMUNOMEDICS, INC. STOCK OPTION AGREEMENT (Filed With SEC on September 13, 2007)

ADDENDUM TO STOCK OPTION AGREEMENT (Filed With SEC on September 13, 2007)

IMMUNOMEDICS, INC. NOTICE OF GRANT OF STOCK OPTION (Filed With SEC on September 13, 2007)

IMMUNOMEDICS, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT (Filed With SEC on September 13, 2007)

ADDENDUM TO RESTRICTED STOCK UNIT ISSUANCE AGREEMENT (Filed With SEC on September 13, 2007)

IMMUNOMEDICS, INC. (Filed With SEC on September 13, 2007)

FIRST ADDENDUM (Filed With SEC on September 13, 2007)

SECOND ADDENDUM (Filed With SEC on September 13, 2007)

American Enterprise Park Morris Plains, New Jersey (Filed With SEC on September 13, 2007)

SPLIT-DOLLAR INSURANCE AGREEMENT (Filed With SEC on September 13, 2007)

COLLATERAL ASSIGNMENT (Filed With SEC on September 13, 2007)

SPLIT-DOLLAR INSURANCE AGREEMENT (Filed With SEC on September 13, 2007)

TERMINATION AGREEMENT (Filed With SEC on September 13, 2007)

Amended and Restated Employment Agreement by and between Immunomedics, Inc. and (Filed With SEC on June 29, 2007)

SUBSCRIPTION AGREEMENT (Filed With SEC on May 2, 2007)

4,848,485 SHARES OF COMMON STOCK of IMMUNOMEDICS, INC. PLACEMENT AGENT AGREEMENT (Filed With SEC on May 2, 2007)

DEVELOPMENT, COLLABORATION AND LICENSE AGREEMENT between (Filed With SEC on August 29, 2006)

Category

Industry

Companies

Contracts

IMMUNOMEDICS INC Contracts & Agreements